Next Generation Cancer Diagnostics Global Market Report 2025

Next Generation Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next generation cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for next generation cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next generation cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Technology: Next-Generation Sequencing (NGS); QPolymerase Chain Reaction And Multiplexing; Lab-On-A-Chip (LOAC) And Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR); Circulating Tumor Deoxyribonucleic Acid (ctDNA) Assays; Protein Microarrays; Deoxyribonucleic Acid Microarrays; Other Multi-Omics Platforms

2) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Cervical Cancer

3) By Function: Therapeutic Monitoring; Companion Diagnostics; Prognostics; Cancer Screening; Risk Analysis

4) By Application: Biomarker Development; Circulating Tumor Cell (CTC) Analysis; Proteomic Analysis; Epigenetic Analysis; Genetic Analysis

5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research And Academic Institutions; Pharmaceutical And Biotechnology Companies; Home Care Settings

Subsegments:

1) By Next-Generation Sequencing: Whole Genome Sequencing; Targeted Gene Sequencing; Exome Sequencing; Transcriptome Sequencing

2) By Quantitative Polymerase Chain Reaction And Multiplexing: Quantitative Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Multiplex Polymerase Chain Reaction; Reverse Transcription Polymerase Chain Reaction

3) By Lab-On-A-Chip And Reverse Transcriptase-Polymerase Chain Reaction: Microfluidic Chip Assays; Integrated Reverse Transcriptase-Polymerase Chain Reaction Chips; Point-of-Care Lab-On-A-Chip Devices; High-Throughput Lab-On-A-Chip Systems

4) By Circulating Tumor Deoxyribonucleic Acid Assays: Single-Gene Circulating Tumor Deoxyribonucleic Acid Assays; Multi-Gene Circulating Tumor Deoxyribonucleic Acid Panels; Digital Droplet Circulating Tumor Deoxyribonucleic Acid Assays; Next-Generation Sequencing Circulating Tumor Deoxyribonucleic Acid Assays

5) By Protein Microarrays: Analytical Protein Microarrays; Functional Protein Microarrays; Reverse Phase Protein Microarrays; Antibody-Based Protein Microarrays

6) By Deoxyribonucleic Acid Microarrays: Gene Expression Deoxyribonucleic Acid Microarrays; Single Nucleotide Polymorphism Genotyping Deoxyribonucleic Acid Microarrays; Comparative Genomic Hybridization Deoxyribonucleic Acid Microarrays; Methylation Deoxyribonucleic Acid Microarrays

7) By Other Multi-Omics Platforms: Metabolomics Platforms; Epigenomics Platforms; Transcriptomics Platforms; Integrated Multi-Omics Systems

Companies Mentioned: F. Hoffmann-La Roche AG; Novartis AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Siemens Healthineers AG; Danaher Corporation; Koninklijke Philips N.V.; General Electric Company; Becton, Dickinson and Company; Agilent Technologies Inc.; Illumina Inc.; Sysmex Corporation; Bio-Rad Laboratories Inc.; Exact Sciences Corporation; QIAGEN N.V.; Almac Group Ltd.; Natera Inc.; Myriad Genetics Inc.; NeoGenomics Inc.; Guardant Health Inc.; Freenome Holdings Inc.; Personalis Inc.; Burning Rock Biotech Limited.; SOPHiA GENETICS S.A.; Singlera Genomics Co. Ltd.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Show more